PHT Corporation Named to Inc. 5000 List of Fastest Growing Private Companies in the U.S. for 3rd Year

eClinical innovator leads the adoption of patient-driven mobile apps for better clinical research

PHT Corporation Named to Inc. 5000 List of Fastest Growing Private Companies in the U.S. for 3rd Year

<0> PHT CorporationBrenda Nashawaty, 617-688-3253 </0>

For the third year earned a place on Inc. 5000, an exclusive ranking of the fastest-growing private companies in the U.S. PHT is the leading provider of technologies used to collect for clinical research.

PHT President and CEO Philip Lee said, “The pharmaceutical and CRO industry’s demand for innovative and valuable eClinical systems continues to grow exponentially. PHT’s growth mirrors this demand as a result of our and our scientific and regulatory delivering a more advantageous eClinical solution.” Phil Lee was a finalist for the Ernst & Young Entrepreneur of the Year award for the second consecutive year.

Additional PHT recognition this year includes being named one of the Boston Business Journal’s 100 largest New England area private companies. PHT Corporation and the PHT LogPad App™, which collects clinical data directly from patients’ own smartphones, are finalists for the Massachusetts Technology Leadership Council’s Private Company and Innovative Technology of the Year awards, respectively. The LogPad App is also currently a semi-finalist in the SCDM data-driven innovation awards; winners will be announced in September.

PHT Corporation helps pharmaceutical companies and CROs conduct clinical trial programs with greater confidence, ease and accuracy. Proven PHT electronic clinical outcome assessment (eCOA) Systems collect patient-driven eData via smartphones, tablets and the web. This data, available via online reporting portal, provides sponsors and clinicians with a real time window into how patients feel and function. PHT has helped trial sponsors collect patient-driven eData in 650+ global trials resulting in 16+ regulatory approvals. PHT offers the regulatory, technological, and scientific expertise today’s market demands and patients deserve. Visit for more information on PHT. Follow PHT on , and .